186 related articles for article (PubMed ID: 36893151)
21. Resolving primary membranous glomerulopathy (MGN) reveals a dynamically metabolic pathway from sub-epithelium to glomerular basement membranes.
Al-Othman YA; Kroneman O; Kumar S; Li W; Kanaan HD; Liu ML; Qu H; Zhang PL
Ultrastruct Pathol; 2022 Jan; 46(1):122-129. PubMed ID: 35109758
[TBL] [Abstract][Full Text] [Related]
22. [An autopsy case of Goodpasture syndrome preceded with membranous glomerulonephritis].
Takeuchi K; Takeda T; Sakai I; Taneichi K; Shibaki H
Ryumachi; 1997 Dec; 37(6):781-7. PubMed ID: 9492565
[TBL] [Abstract][Full Text] [Related]
23. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
Honkanen E; Teppo AM; Törnroth T; Groop PH; Grönhagen-Riska C
Nephrol Dial Transplant; 1997 Dec; 12(12):2562-8. PubMed ID: 9430852
[TBL] [Abstract][Full Text] [Related]
24. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
Wehrmann M; Bohle A; Bogenschütz O; Eissele R; Freislederer A; Ohlschlegel C; Schumm G; Batz C; Gärtner HV
Clin Nephrol; 1989 Feb; 31(2):67-76. PubMed ID: 2920470
[TBL] [Abstract][Full Text] [Related]
25. Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia.
Yahata N; Kawanishi Y; Okabe S; Kimura Y; Okada T; Otani M; Shimizu T; Nakao T; Ohyashiki K
Am J Nephrol; 2000; 20(5):402-7. PubMed ID: 11092999
[TBL] [Abstract][Full Text] [Related]
26. Subclinical acquired syphilis masquerading as membranous glomerulonephritis.
Soehardy Z; Hayati SN; Rozita M; Rohana AG; Halim AG; Norella K; Phang KS
Med J Malaysia; 2006 Oct; 61(4):484-6. PubMed ID: 17243528
[TBL] [Abstract][Full Text] [Related]
27. Histopathological atlas of renal diseases: membranous glomerulonephritis.
Ferrario F; Rastaldi MP
J Nephrol; 2004; 17(5):635-6. PubMed ID: 15593028
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.
Kazi JI; Mubarak M; Ahmed E; Akhter F; Naqvi SA; Rizvi SA
Clin Exp Nephrol; 2009 Feb; 13(1):38-43. PubMed ID: 18685922
[TBL] [Abstract][Full Text] [Related]
29. Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody.
Hou Y; Zhang C; Yu X; Wang W; Zhang D; Bai Y; Yan C; Ma L; Li A; Ji J; Cao L; Wang Q
Front Immunol; 2022; 13():939062. PubMed ID: 35958552
[TBL] [Abstract][Full Text] [Related]
30. Morphological pattern of glomerular diseases in adult nephrotic syndrome.
Huq N; Khatun H; Jinnah SA
Mymensingh Med J; 2011 Oct; 20(4):652-7. PubMed ID: 22081185
[TBL] [Abstract][Full Text] [Related]
31. Segmental membranous nephropathy.
Choung HYG; Goldman B
Clin Exp Nephrol; 2021 Jul; 25(7):700-707. PubMed ID: 33755821
[TBL] [Abstract][Full Text] [Related]
32. Validation of phospholipase A
Dai P; Campbell D; Culican S; Brown DA; Byth K; Hissaria P; Ninnes R; Nankivell B; Lin MW
Pathology; 2020 Aug; 52(5):546-551. PubMed ID: 32564921
[TBL] [Abstract][Full Text] [Related]
33. [Membranous glomerulonephritis in 10 diabetics].
Ditscherlein G; Schneider W
Zentralbl Allg Pathol; 1983; 127(3-4):245-51. PubMed ID: 6880436
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group.
Sloan RP; Schwartz MM; Korbet SM; Borok RZ
J Am Soc Nephrol; 1996 Feb; 7(2):299-305. PubMed ID: 8785400
[TBL] [Abstract][Full Text] [Related]
35. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
[TBL] [Abstract][Full Text] [Related]
36. Effect of monovalency on anti-contactin-1 IgG4.
Taieb G; Jentzer A; Vegezzi E; Lleixà C; Illa I; Querol L; Devaux JJ
Front Immunol; 2023; 14():1021513. PubMed ID: 36999029
[TBL] [Abstract][Full Text] [Related]
37. Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy.
Le Quintrec M; Teisseyre M; Bec N; Delmont E; Szwarc I; Perrochia H; Machet MC; Chauvin A; Mavroudakis N; Taieb G; Lanfranco L; Rigothier C; José B; Concetta C; Geneste C; Pernin V; Larroque C; Devaux J; Beyze A
Kidney Int; 2021 Dec; 100(6):1240-1249. PubMed ID: 34600965
[TBL] [Abstract][Full Text] [Related]
38. Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts.
Kearney N; Podolak J; Matsumura L; Houghton D; Troxell M
Transplant Proc; 2011 Dec; 43(10):3743-6. PubMed ID: 22172838
[TBL] [Abstract][Full Text] [Related]
39. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD
Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361
[TBL] [Abstract][Full Text] [Related]
40. Membranous glomerulopathy with Bowman's capsular and tubular basement membrane deposits.
Markowitz GS; Kambham N; Maruyama S; Appel GB; Cohen DJ; Kim RC; Andres GA; D'Agati VD
Clin Nephrol; 2000 Dec; 54(6):478-86. PubMed ID: 11140809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
